Zhicheng Wang , Pengyun Meng , Qianyi Xia , Zixuan Yang , Chang Lu , Haomin Yang , Jiantuo Yu
{"title":"Social inequalities in lung cancer screening in China: a cross-sectional study","authors":"Zhicheng Wang , Pengyun Meng , Qianyi Xia , Zixuan Yang , Chang Lu , Haomin Yang , Jiantuo Yu","doi":"10.1016/j.lanwpc.2024.101317","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Lung cancer is the leading cause of cancer-related deaths in China, while screening for lung cancers offers an opportunity for early detection and reduced mortality. Limited data exist on nationwide lung cancer screening uptake in China, particularly concerning social inequalities. This study aims to assess lung cancer screening uptake situation in China, examine sociodemographic factors associated with screening participation, and identify barriers to screening, particularly in relation to social inequalities.</div></div><div><h3>Methods</h3><div>Between September 2022 and January 2023, we conducted the Chinese Residents Cancer Screening Services Survey, assessing uptake and willingness to participate in screening for various cancers, including lung cancer. The survey included a nationally representative sample of 10,000 adults aged 35-69 from 100 counties and districts across 26 provinces. Lung cancer screening uptake was defined as prior participation in chest or lung CT scans for cancer screening or detection. Key variables examined include age, gender, smoking habits, and individual-level and area-level socioeconomic status.</div></div><div><h3>Findings</h3><div>Lifetime lung cancer screening rates were 37.21% (95% CI 35.83-38.61) for men and 39.58% (95% CI 38.26-40.92) for women, while screening within the past five years was 34.42% (95% CI 33.07-35.80) for men and 37.47% (95% CI 36.16-38.80) for women. Smokers had the lowest uptake (33.97%, 95% CI 32.12-35.86) compared to ever-smokers (46.77%, 95% CI 43.05-50.51) and never-smokers (39.25%, 95% CI 38.08-40.42). Rural residents had lower uptake (26.59%, 95%CI 25.03-28.20) compared to urban residents (43.67%, 95%CI 42.50-44.84). Education and income levels were strongly associated with screening participation, with higher rates in richer and educated individuals. Area-level social inequalities were also notable, with screening uptake ranging from 56.87% (95% CI 54.32-59.39) in the least deprived 10% counties to 26.00% (95% CI 22.21-30.08) in the most deprived 10%. Across all socioeconomic groups, the primary reason for not participating in cancer screening was the belief that their risk of cancer was too low, while socially vulnerable groups were more likely to be deterred by screening costs or fear of a cancer diagnosis.</div></div><div><h3>Interpretation</h3><div>Lung cancer screening uptake in China remains low, particularly among smokers. Notable social inequalities in screening participation were identified, with lower uptake among rural residents and individuals with socioeconomic disadvantages at both the individual and area levels. Targeted public health interventions are crucial to raise awareness and improve access to lung cancer screening, especially in underserved communities.</div></div><div><h3>Funding</h3><div>China Development Research Foundation.</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"55 ","pages":"Article 101317"},"PeriodicalIF":8.1000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Lancet Regional Health: Western Pacific","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666606524003110","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/17 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Lung cancer is the leading cause of cancer-related deaths in China, while screening for lung cancers offers an opportunity for early detection and reduced mortality. Limited data exist on nationwide lung cancer screening uptake in China, particularly concerning social inequalities. This study aims to assess lung cancer screening uptake situation in China, examine sociodemographic factors associated with screening participation, and identify barriers to screening, particularly in relation to social inequalities.
Methods
Between September 2022 and January 2023, we conducted the Chinese Residents Cancer Screening Services Survey, assessing uptake and willingness to participate in screening for various cancers, including lung cancer. The survey included a nationally representative sample of 10,000 adults aged 35-69 from 100 counties and districts across 26 provinces. Lung cancer screening uptake was defined as prior participation in chest or lung CT scans for cancer screening or detection. Key variables examined include age, gender, smoking habits, and individual-level and area-level socioeconomic status.
Findings
Lifetime lung cancer screening rates were 37.21% (95% CI 35.83-38.61) for men and 39.58% (95% CI 38.26-40.92) for women, while screening within the past five years was 34.42% (95% CI 33.07-35.80) for men and 37.47% (95% CI 36.16-38.80) for women. Smokers had the lowest uptake (33.97%, 95% CI 32.12-35.86) compared to ever-smokers (46.77%, 95% CI 43.05-50.51) and never-smokers (39.25%, 95% CI 38.08-40.42). Rural residents had lower uptake (26.59%, 95%CI 25.03-28.20) compared to urban residents (43.67%, 95%CI 42.50-44.84). Education and income levels were strongly associated with screening participation, with higher rates in richer and educated individuals. Area-level social inequalities were also notable, with screening uptake ranging from 56.87% (95% CI 54.32-59.39) in the least deprived 10% counties to 26.00% (95% CI 22.21-30.08) in the most deprived 10%. Across all socioeconomic groups, the primary reason for not participating in cancer screening was the belief that their risk of cancer was too low, while socially vulnerable groups were more likely to be deterred by screening costs or fear of a cancer diagnosis.
Interpretation
Lung cancer screening uptake in China remains low, particularly among smokers. Notable social inequalities in screening participation were identified, with lower uptake among rural residents and individuals with socioeconomic disadvantages at both the individual and area levels. Targeted public health interventions are crucial to raise awareness and improve access to lung cancer screening, especially in underserved communities.
肺癌是中国癌症相关死亡的主要原因,而肺癌筛查为早期发现和降低死亡率提供了机会。关于中国全国范围内肺癌筛查的数据有限,特别是关于社会不平等的数据。本研究旨在评估中国肺癌筛查的接受情况,研究与筛查参与相关的社会人口因素,并确定筛查的障碍,特别是与社会不平等有关的障碍。方法:在2022年9月至2023年1月期间,我们进行了中国居民癌症筛查服务调查,评估了包括肺癌在内的各种癌症筛查的接受程度和参与意愿。该调查包括来自26个省100个县区的1万名年龄在35岁至69岁之间的成年人。肺癌筛查摄取被定义为先前参与胸部或肺部CT扫描以进行癌症筛查或检测。研究的关键变量包括年龄、性别、吸烟习惯、个人和地区的社会经济地位。男性终身肺癌筛查率为37.21% (95% CI 35.83-38.61),女性为39.58% (95% CI 38.26-40.92),而过去5年的筛查率男性为34.42% (95% CI 33.07-35.80),女性为37.47% (95% CI 36.16-38.80)。与从不吸烟者(46.77%,95% CI 43.05-50.51)和从不吸烟者(39.25%,95% CI 38.08-40.42)相比,吸烟者的摄取最低(33.97%,95% CI 32.12-35.86)。农村居民的接种率(26.59%,95%CI 25.03 ~ 28.20)低于城镇居民(43.67%,95%CI 42.50 ~ 44.84)。受教育程度和收入水平与筛查参与率密切相关,在富裕和受教育程度较高的人群中,这一比例更高。地区层面的社会不平等也很显著,最贫困的10%县的筛查覆盖率从56.87% (95% CI 54.32-59.39)到最贫困的10%县的26.00% (95% CI 22.21-30.08)不等。在所有社会经济群体中,不参加癌症筛查的主要原因是认为自己患癌症的风险太低,而社会弱势群体更有可能因筛查费用或对癌症诊断的恐惧而却步。中国的肺癌筛查率仍然很低,尤其是在吸烟者中。在筛查参与方面发现了明显的社会不平等,在个人和地区层面上,农村居民和社会经济劣势个体的接受程度较低。有针对性的公共卫生干预措施对于提高认识和改善获得肺癌筛查的机会至关重要,特别是在服务不足的社区。中国发展研究基金会。
期刊介绍:
The Lancet Regional Health – Western Pacific, a gold open access journal, is an integral part of The Lancet's global initiative advocating for healthcare quality and access worldwide. It aims to advance clinical practice and health policy in the Western Pacific region, contributing to enhanced health outcomes. The journal publishes high-quality original research shedding light on clinical practice and health policy in the region. It also includes reviews, commentaries, and opinion pieces covering diverse regional health topics, such as infectious diseases, non-communicable diseases, child and adolescent health, maternal and reproductive health, aging health, mental health, the health workforce and systems, and health policy.